Ocular Therapeutix Inc (OCUL : NASDAQ)
Common Stock
$9.87
USD
+0.00 (%)
Last updated: 2026-09-17
Get OCUL alerts:
OCUL
Ocular Therapeutix Inc
WealthAwesomePerformance
1 Day
-3.14%
1 Week
-13.95%
1 Month
-7.32%
YTD
+2.39%
Key Statistics
Market Cap
$2.17B
52W High
$16.44
52W Low
$6.23
P/E Ratio
-
50 Day MA
$9.89
200 Day MA
$9.91
Beta
0.97
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/17/2026 | $10.11 | $10.54 | $10.05 | $10.14 | $10.14 | 2,310,277 |
| 9/16/2026 | $10.21 | $10.32 | $9.81 | $9.87 | $9.87 | 3,400,353 |
| 9/15/2026 | $10.79 | $10.89 | $10.13 | $10.19 | $10.19 | 2,098,599 |
| 9/14/2026 | $10.61 | $10.85 | $10.49 | $10.72 | $10.72 | 1,623,509 |
| 9/11/2026 | $10.75 | $10.94 | $10.37 | $10.49 | $10.49 | 2,638,751 |
| 9/10/2026 | $11.43 | $11.43 | $10.54 | $10.62 | $10.62 | 2,391,600 |
| 9/9/2026 | $11.24 | $11.48 | $11.02 | $11.47 | $11.47 | 2,804,000 |
| 9/8/2026 | $10.56 | $11.44 | $10.40 | $11.37 | $11.37 | 2,736,600 |
| 9/4/2026 | $10.51 | $10.77 | $10.51 | $10.64 | $10.64 | 1,306,900 |
| 9/3/2026 | $10.98 | $11.08 | $10.41 | $10.64 | $10.64 | 2,128,700 |
Analyst Price Targets
Based on 12 analysts covering OCUL · as of Sep 17, 2026
Wall Street analysts forecast OCUL stock price to rise 174.5% over the next 12 months.
Consensus
Strong Buy4.50 / 5.00
Avg. Target
US$27.09
+174.5% Upside
Current Price
US$9.87
Last close
Analyst Breakdown (12 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on OCUL's historical volatility
30-Day Vol
58.5%
Annualized
90-Day Vol
53.1%
Annualized
Trend (90d)
+1.0%
Annualized drift
90d Mean
US$10.18
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$10.15 | US$8.30 – US$12.42 |
| 60 trading days | US$10.17 | US$7.64 – US$13.52 |
| 90 trading days | US$10.18 | US$7.17 – US$14.44 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Ocular Therapeutix Inc
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that is in phase 3 clinical trials for the treatment of wet age-related macular degeneration and non-proliferative diabetic retinopathy; OTX-TIC, a travoprost intracameral hydrogel, which has completed phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension. The company has a license agreement and collaboration with AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.
Financials
- Revenue (TTM)
- $52.05M
- EBITDA
- $-308.46M
- Profit Margin
- 0.00%
- ROE (TTM)
- -72.99%
- EPS (Diluted)
- -1.40
- Book Value
- 2.37
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About OCUL.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| DLXY | Delixy Holdings Limited Ordinary Shares | $2.29 | +451.81% |
| MEDS | DataMEDS AI, Inc. | $6.07 | +274.69% |
| SNYR | Synergy CHC Corp. Common Stock | $0.27 | +234.15% |
| QCLS | Q/C Technologies, Inc. | $0.96 | +118.45% |
| AEHL | Antelope Enterprise Holdings Ltd | $9.22 | +78.68% |
| ZTG | Zenta Group Company Limited | $1.18 | +75.33% |
| PDSB | PDS Biotechnology Corp | $0.99 | +69.25% |
| TPST | Tempest Therapeutics Inc | $1.21 | +60.18% |